Tamsulosin HCL SR Pellets
Tamsulosin HCL SR Pellets – Sustained-Release Alpha Blocker Pellets for BPH Formulations. Rraynex Tamsulosin HCL SR Pellets are engineered as a modified-release multiparticulate system for benign prostatic hyperplasia (BPH) therapies requiring consistent sustained-release behavior and reliable capsule filling.
Product overview
Tamsulosin hydrochloride sustained-release pellets use controlled release technology to support once-daily BPH formulations. Rraynex controls pellet size, coating and in-process dissolution to deliver predictable multiparticulate performance. Technical specifications are available upon request.
Key characteristics
- Sustained-release alpha blocker pellet system.
- Controlled coating for modified release.
- Uniform particle size for MUPS and capsule filling.
- Suitable for BPH pharmaceutical development and commercial supply.
Product specifications
- Product
- Tamsulosin HCL SR Pellets
- Form
- sustained-release Pellets
- Therapeutic category
- Alpha-Blocker
- Strength
- 0.16%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Tamsulosin HCL SR Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Tamsulosin products from Rraynex
- Tamsulosin + Dutasteride — Pellets
- Tamsulosin + Dutasteride (0.4% + 0.5%) — Pellets
- Tamsulosin HCl + Tadalafil (Blended) — Pellets
- Tamsulosin HCl SR (WW) — Pellets
- Tamsulosin HCl SR + Dutasteride IR (WW) — Pellets